| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000261280.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.042488724 |
Resistant |
| ENSG00000261280.2 |
Afatinib |
Head and neck squamous cell carcinoma |
0.009472781 |
Sensitive |
| ENSG00000261280.2 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025099321 |
Sensitive |
